These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33892052)

  • 1. Extrachromosomal DNA: Redefining the pathogenesis of glioblastoma.
    Shiras A; Mondal A
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188551. PubMed ID: 33892052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma.
    deCarvalho AC; Kim H; Poisson LM; Winn ME; Mueller C; Cherba D; Koeman J; Seth S; Protopopov A; Felicella M; Zheng S; Multani A; Jiang Y; Zhang J; Nam DH; Petricoin EF; Chin L; Mikkelsen T; Verhaak RGW
    Nat Genet; 2018 May; 50(5):708-717. PubMed ID: 29686388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
    Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM
    Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.
    Lan Z; Li X; Zhang X
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrachromosomal circular DNA in colorectal cancer: biogenesis, function and potential as therapeutic target.
    Chen Y; Qiu Q; She J; Yu J
    Oncogene; 2023 Mar; 42(13):941-951. PubMed ID: 36859558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs involved in the EGFR pathway in glioblastoma.
    Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J
    Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated Insights on EGFR Signaling Pathways in Glioma.
    Oprita A; Baloi SC; Staicu GA; Alexandru O; Tache DE; Danoiu S; Micu ES; Sevastre AS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.
    Hutóczki G; Bognár L; Tóth J; Scholtz B; Zahuczky G; Hanzély Z; Csősz É; Reményi-Puskár J; Kalló G; Hortobágyi T; Klekner A
    Pathol Oncol Res; 2016 Jan; 22(1):155-60. PubMed ID: 26450124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key concepts in glioblastoma therapy.
    Bartek J; Ng K; Bartek J; Fischer W; Carter B; Chen CC
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):753-60. PubMed ID: 22396442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.
    Wick W; Dettmer S; Berberich A; Kessler T; Karapanagiotou-Schenkel I; Wick A; Winkler F; Pfaff E; Brors B; Debus J; Unterberg A; Bendszus M; Herold-Mende C; Eisenmenger A; von Deimling A; Jones DTW; Pfister SM; Sahm F; Platten M
    Neuro Oncol; 2019 Jan; 21(1):95-105. PubMed ID: 30277538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational analysis and verification of molecular genetic targets for glioblastoma.
    Xue L; Liu H; Chen Y; Wei L; Hong J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
    J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the epigenetics of glioblastomas.
    Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
    Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targets in glioblastoma.
    Zorzan M; Giordan E; Redaelli M; Caretta A; Mucignat-Caretta C
    Future Oncol; 2015; 11(9):1407-20. PubMed ID: 25952786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic extrachromosomal DNA functions as mobile enhancers to globally amplify chromosomal transcription.
    Zhu Y; Gujar AD; Wong CH; Tjong H; Ngan CY; Gong L; Chen YA; Kim H; Liu J; Li M; Mil-Homens A; Maurya R; Kuhlberg C; Sun F; Yi E; deCarvalho AC; Ruan Y; Verhaak RGW; Wei CL
    Cancer Cell; 2021 May; 39(5):694-707.e7. PubMed ID: 33836152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression.
    Liao Z; Jiang W; Ye L; Li T; Yu X; Liu L
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188392. PubMed ID: 32735964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.